The board meeting for Neurocrine Biosciences, Inc. is scheduled for today, for the purpose of Stifel 2025 Virtual CNS ForumSee details
Neurocrine Biosciences, Inc. - NBIX - stock price prediction, stock price target, analyst ratings from 26 analysts
Neurocrine Biosciences, Inc. has a share price target of US$ 164, revenue growth forecast of 13.6%, and profit growth estimate of 23.1% for FY25, based on top 26 analyst calls.